An experimental and closely watched medicine for Alzheimer’s disease is one step closer to approval, after receiving support from a...
Medicine
Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief:...
Dive Brief: Radiopharmaceutical drug developer ITM has raised 188 million euros, or about $205 million, to fund its development of...
Dive Brief: Seres Therapeutics plans to sell all the rights to its microbiome pill to Nestlé Health Science as it...
After a turbulent few years, 2024 has given the biotechnology industry some signs of a return to normalcy. For one,...
Dive Brief: Expert advisers to the Food and Drug Administration will need to weigh whether Eli Lilly’s experimental Alzheimer’s disease...
Long dismissed by top scientists and drug regulators, the use of psychedelics to treat mental health conditions has finally gained...
Today, several brief updates from BioPharma Dive Reporter Gwendolyn Wu, who spent this week attending BIO’s annual meeting in San...
Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. British drugmaker...
A group of advisers to the Food and Drug Administration on Wednesday unanimously recommended that COVID-19 vaccines be updated to...